Dr. Daniel George on the Treatment Landscape for RCC
Cancer Network spoke with Daniel George, MD, of Duke Health, about the treatment landscape and current trials for renal cell carcinoma.
Can mRCC Patients Be Spared Debulking Nephrectomy?
In this video, Dr. Daniel George discusses CARMENA, which asked if cytoreductive surgery is necessary in the age of active systemic therapy for mRCC.